HIGH QUALITY SERVICE

high technology innovation , high speed development.

HIGH QUALITY SERVICE

胃癌 TMA

上海芯超生物科技有限公司 
生物芯片上海国家工程研究中心

上海市高新技術企業

  • 上海芯超生物科技有限公司成立於2003年12月18日
  • 為美國BIOXXX 組織晶片公司之上游供應商

擁有十五863消化道腫瘤組織庫與組織芯片重大項目、十一五863胰腺癌基因組重大項目、衛生部肝癌組織芯片分子標記物篩選重大項目、863胃癌易感基因與幽門螺桿菌耐藥基因聯合檢測重點項目。

商品介紹

Catalog

Diameter

Dots

Cases

Description

HGEj-Ade130Sur-01

(gastroesophageal junction)

1.5mm

130

65

1. Gastroesophageal junctional carcinoma, 65 cases.
2. Survival information available, being followed up for 3.5-7 years.

HStmA030PG02

(stomach)

2.0mm

60

30

gastric adenocarcinoma 30 cases: 1 core/case, grade I-Ⅲ.

HStmA030PG03

(stomach)

2.0mm

30

15

1.Gastric adenocarcinoma (15 cases),  tumor (1 core/case) and matched normal adjacent tissue (1 core/case).   Pathology grade 2.
2. Reproduce of HCol-Ade030PG-01 (14 cases overlapped)

HStmA050Me01

(stomach)

2.0mm

50

26

21 cases of metastasis of gastric cancer：primary/NAT/metastasis(7 cases)，primary/NAT(5 cases),primary/metastasis( 5 cases),5 cases of metastasis.5 cases of normal gastric mucosa.

HStmA150Su01

(stomach)

1.5mm

150

55

1. Gastric adenocarcinoma 95 cases: 55 cases have tumor (1 core/case ) and matched normal adejacent tissue (1 core/case);40 cases have tumor tissue(1 core/case).
2. Survival information available.Surgery date 2002.5－2004.5,visite date 2011.12.Being followed up for 7.6-7.8 years.

HStmA180Su08

(stomach)

1.5mm

180

100

1. 100 cases gastric adenocarcinoma with survival information,100 cores tumor and matched 80 cores of NAT.Clinical stage from Ⅰto Ⅳ(AJCC 7.0). Surgery date2006.7－2007.4， visit date 2014.9.Being followed up for 7.4－8.1 years.69 deceased cases,79 cases overlapped with HStm-Ade180Sur-05.
2. 2015.07 update follow-up.

HStm-Ade030PG-01

(stomach)

2.0mm

30

15

1.  Gastric adenocarcinoma, 15 cases, have tumor (1 core/case) or normal adjacent tissue (1 core/case). 
2.  Grade 2,3.

HStm-Ade040PG-01

(stomach)

2.0mm

40

20

1. Gastric adenocarcinoma (20 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case).
2. Pathology grade 1, 2, 3.

HStm-Ade040PG-02

(stomach)

2.0mm

40

40

1. Gastric adenocarcinoma (40 cases), 1 core/case.
2. Pathology grade 1, 2, 3.
3. Paired frozen tissue accessible.

HStm-Ade060CS-01

(stomach)

2.0mm

60

30

1.4 cases of normal gastric mucosa.28 cases of gastric adenocarcinoma with matched normal adjacent tissue, 1 core/case.
2. Clinical stage(AJCC 7.0)I  II III  IV. With TNM score.

HStm-Ade060PG-01

(stomach)

2.0mm

60

30

1. Gastric adenocarcinoma (30 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 
2. Pathology grade1 (2 cases), 1-2 (3 cases), 2 (9 cases), 2-3  (4 cases), 3 (12 cases).

HStm-Ade076Met-01

(stomach)

2.0mm

76

31

1. Gastric carcinoma, 13 cases have normal adjacent tissue, primary foci and metastases.  14 cases have primary foci and metastases, 4 cases of which have two metastases.  1 case have recurrent tumor foci and metastases. 3 cases have metastases.

HStm-Ade080CD-01

(stomach)

1.5mm

80

80

1. Progression of gastric carcinoma: normal gastric mucosa tissue, distal gastric mucosa tissue, adjacent gastric mucosa tissue, primary focus of gastric cancer, hepatic metastases of gastric cancer, negative lymph node, positive lymph node.
2. 80 cases, 1 core/case.

HStm-Ade080CD-02

(stomach)

2.0mm

80

　

1. Progession of gastric cancer: normal gastric mucosa tissue ,gastric intraepithelialneoplasia, primary focus of gastric cancer( Clinical stage I-IV),adjacent mucosa tissue, metastases of gastric cancer, negative lymph node, positive lymph node.
 2. 5~23 cases for each progressin, 1 core/case. 

HStm-Ade090PG-01

(stomach)

1.5mm

90

30

1. Gastric adenocarcinoma (30 cases), tumor, normal adjacent tissue and distant normal tissue.
2. Pathology grade 1-2, 2, 3.

HStm-Ade120Lym-01

(stomach)

1.5mm

120

40

1. Gastric adenocarcinoma (40 cases), tumor tissue (1 core/case) & matched normal adjacent tissue (1 core/case) & matched negative or positive lymph nodes (1 core/case).
2. Clinical stage (Version 7.0), N0 (8 cases), N1 (3 cases), N2 (13 cases), N3a (11 cases), N3b (5 cases).

HStm-Ade150CS-01

(stomach)

1.5mm

150

75

 1. stomach adenocarcinoma, 75 cases. Tumor and normal adjacent tissue. 2 cores/case.
2. 15 cases of clinical Stage I  . 25 cases of stage II, 25 cass of  stage III, 10 cases of stage IV.(all cases overlapped with HStm-Ade180CS-01 )

HStm-Ade150CS1-01

(stomach)

1.5mm

150

75

1. Early stomach adenocarcinoma, 75 cases. Tumor and normal adjacent tissue. 2 cores/case.
2. Clinical Stage I. 29 cases of T1N0M0, 5 cass of T1N1M0, 41 cases of T2N0M0.

HStm-Ade150CS-01

(stomach)

1.5mm

150

75

1. Advanced stomach adenocarcinoma, 75 cases. Tumor and normal adjacent tissue. 2 cores/case.
2. Clinical Stage IV.

HStm-Ade167Sur-01

(stomach)

1.5mm

167

92

1. Gastric adenocarcinoma (92 cases) with survival information. 
2. 75 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case), 17 cases have tumor (1 core/case) or normal adjacent tissue (1 core/case). 
3. Clinical stage I-IV (version 7.0).  
4. Being followed up for 6.3-7.1 years.
5. 2015.07 update follow-up

HStm-Ade180Sur-02

(stomach)

1.5mm

180

90

1. Gastric adenocarcinoma (90 cases) with survival information.
2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).  
3. Clinical stage I-IV (Version 7.0).  
4. Being followed up for 5-5.5 years. VEGF and survivin information available.
5. 2015.07 update follow-up

HStm-Ade180Sur-04

(stomach)

1.5mm

180

90

1. Gastric adenocarcinoma (90 cases) with survival information.
2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).  
3. Clinical stage I-IV (Version 7.0).  
4. Being followed up for 5.5-6.3 years.
5. 2015.07 update follow-up

HStm-Ade180Sur-05

(stomach)

1.5mm

180

90

1. Gastric adenocarcinoma (90 cases) with survival information.
2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).  
3. Clinical stage I-IV (Version 7.0).  
4. Being followed up for 6.3-7.1 years.
5. 2015.07 update follow-up

HStm-Ade180Sur-06

(stomach)

1.5mm

180

90

1. Gastric adenocarcinoma (90 cases) with survival information.
2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).  
3. Clinical stage I-IV (Version 7.0).  
4. Being followed up for 5.5-6 years. Visit Date on 2014.09
5. 2015.07 update follow-up

HStm-Ade180Sur-07

(stomach)

1.5mm

180

90

1. Gastric adenocarcinoma (90 cases) with survival information.
2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).  
3. Clinical stage I-IV (Version 7.0).  
4. Being followed up for 4.3-4.9 years.
5. 2015.07 update follow-up

HStm-Can090PT-01

(stomach)

1.5mm

90

45

45 cases of gastric cancer,tumor with matched normal adjacent tissue, 1 core/case. Papillary adenocarcinoma, tubular adenocarcinoma,mucous adenocarcinoma, signet-ring cell carcinoma,mixed-adnocarcinoma;squamous cell carcinoma,  adenosquamous carcinoma, undifferetiated carcinoma,hepatoid adenocarcinoma.

HStm-Dis030PT-01

(stomach)

2.0mm

30

24

Various gastric diseaases, 1 core/case:normal gastric mucosa, gastric ulcer, gastric polyps and gastric intraepithelial neoplasia, gastric carcinoma/normal adjacent tissue

HStm-Muc060CS-01

(stomach)

2.0mm

60

30

1.30 cases of mucinous adenocarcinoma with matched normal adjacent tissue, 1 core/case.
2.Clinical stage(AJCC 7.0)I  II III  IV

HStm-Sig060CS-01

(stomach)

2.0mm

60

30

1. 30 cases of signet ring cell carcinoma with matched normal adjacent tissue, 1 core/case.
2.   Clinical stage(AJCC 7.0)I  II III  IV.Most of Pathology Grade 3. 

HStm-Tub060CS-01

(stomach)

2.0mm

60

30

1. 30 cases of gastric tubular adenocarcinoma with matched normal adjacent tissue
2. Clinical stage(AJCC 7.0)I  II III  IV

OD-CT-DgStm01-002

(stomach)

1.0mm

200

110

1. Gastric adenocarcinoma (90 cases), 2 cores/case.  Pathology grade Ⅱ, Ⅲ. 
2. Adjacent normal tissue (8 cases), 1 core/case. 
3. Other carcinoma (12 cases), containing esophagus squamous cell carcinoma (2 cases), hepatocellular carcinoma (2 cases), colon adenocarcinoma (2 cases), rectum adenocarcinoma (2 cases), lung cancer (2 cases) and renal clear cell carcinoma (2 cases).1core/case.

OD-CT-DgStm01-003

(stomach)

1.5mm

136

34

1. Gastric adenocarcinoma (28 cases) and esophagogastric junction carcinoma (6 cases). 
2. tumor (1 core/case) and matched normal adjacent tissue (3 cores/case). 
3. Clinical stage I-IV (Version 7.0).  
4. 70% cases have TNM detail information. 
5. Pathology grade 2, 3.

OD-CT-DgStm01-007

(stomach)

1.0mm

390

130

1. Gastric carcinoma (110 cases), containing gastric carcinoma (83 cases) and esophagogastric junction carcinoma (27 cases).
2. Normal adjacent tissue (20 cases), containing adjacent normal mucosa tissue (10 cases), chronic gastritis (10 cases). 3 cores/case.
3. Clinical stage I-IV (Version 7.0). 
4. 31 cases have survival information.

OD-CT-DgStm01-013

(stomach)

1.5mm

184

92

1.Gastric adenocarcinoma (92 cases), containing tubular adenocarcinoma (30 cases), mucinous adenocarcinoma (31 cases), signet ring cell carcinoma (30 cases).
2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).
3. Clinical stage I-IV (version 7.0).
4. 60% cases have TNM detail information.
5. 26 cases have survival information.

OD-CT-DgStm02-001

(stomach)

2.0mm

32

32

1. Gastric adenocarcinoma (32 casee), 1 core/case.
2. Pathology grade 1, 1-2

OD-CT-DgStm02-003

(stomach)

2.0mm

32

32

1. Gastric adenocarcinoma (31 cases), adenosquamous carcinoma (1 case), undifferentiated carcinoma (1 case), 1 core/case. 
2. Pathology grade 3.

OD-CT-DgStm03-002

(stomach)

2.0mm

62

31

1. Gastric adenocarcinoma (27 cases) and esophagogastric junction carcinoma (4 cases). 
2. tumor (1 core/case) and matched normal adjacent tissue (1 core/case) 
3. Clinical stage II, III, IV (Version 7.0). 
4. 70% cases have TNM detail information. 
5. Pathology grade 1, 2, 3.

OD-CT-DgStm03-003

(stomach)

2.0mm

62

31

1. Gastric carcinoma (31 cases), containing squamous cell carcinoma (6 cases), tubular adenocarcinoma (6 cases), mucinous adenocarcinoma (6 cases), signet ring cell carcinoma (7 cases) and undifferentiated carcinoma (6 cases). 
2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).  
3. Clinical stage I, II, III (Version 7.0).
4. 80% cases have TNM detail information.   
5. 15 cases have survival information.

OD-CT-DgStm04-001
(stomach)

1.5mm

85

45

1. Gastric adenocarcinoma (40 cases), 2 cores/case. Normal adjacent tissue (5 cases), 1 core/case.  
2. Pathology grade 2, 3.
3. Clinical stage I, II, III (Version 7.0).